The Venture Codex Logo

The Venture Codex

British Patient Capital

Steel City House, 2 West Street, Sheffield, South Yorkshire, S1 2GQ, United Kingdom

Overview

Invests in venture and growth capital funds for innovative companies.

Founded

2018

Deals · 12mo

1

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B
Series C

Geographic focus

United Kingdom

Sector focus

—

Investment portfolio

37rounds
NAMEDATESIZE
Iceotope
May 2026Participated
$26 MSeries B
Maxion Therapeutics
Mar 2025Participated
$78 MSeries A
Quantexa
Mar 2025Participated
$175 MSeries F
Cambridge GaN Devices
Feb 2025Participated
$32 MSeries C
Tokamak Energy
Nov 2024Participated
$125 MOther Equity
Nuclera
Oct 2024Participated
$77 MSeries C
Purespring Therapeutics
Oct 2024Participated
$107 MSeries B
Form3
Sep 2024Led
$60 MSeries C
Epsilogen
Sep 2024Participated
$16 MSeries B
Myricx Bio
Jul 2024Participated
$115 MSeries A
Greywolf Therapeutics
May 2024Participated
$50 MSeries B
Stream
Apr 2024Participated
$22 MOther Equity
Iceotope
May 2026Participated
$26 MSeries B
Maxion Therapeutics
Mar 2025Participated
$78 MSeries A
Quantexa
Mar 2025Participated
$175 MSeries F
Cambridge GaN Devices
Feb 2025Participated
$32 MSeries C
Tokamak Energy
Nov 2024Participated
$125 MOther Equity
Nuclera
Oct 2024Participated
$77 MSeries C
Purespring Therapeutics
Oct 2024Participated
$107 MSeries B
Form3
Sep 2024Led
$60 MSeries C
Epsilogen
Sep 2024Participated
$16 MSeries B
Myricx Bio
Jul 2024Participated
$115 MSeries A
Greywolf Therapeutics
May 2024Participated
$50 MSeries B
Stream
Apr 2024Participated
$22 MOther Equity
37
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

British Patient Capital: 37 funding rounds are recorded in the selected participation categories.All available history.
British Patient Capital: 37 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A06
Series B114
Series C+212
Other Equity02

Monthly Deal Activity

British Patient Capital: 37 deals are recorded across 76 months.All available history.
British Patient Capital: 37 deals are recorded across 76 months. All available history
MonthDeals
Jul '201
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '211
Aug '210
Sep '211
Oct '210
Nov '213
Dec '210
Jan '220
Feb '220
Mar '223
Apr '220
May '220
Jun '221
Jul '222
Aug '220
Sep '220
Oct '221
Nov '220
Dec '222
Jan '232
Feb '232
Mar '230
Apr '231
May '231
Jun '230
Jul '231
Aug '230
Sep '230
Oct '230
Nov '230
Dec '231
Jan '240
Feb '241
Mar '241
Apr '241
May '241
Jun '240
Jul '241
Aug '240
Sep '242
Oct '242
Nov '241
Dec '240
Jan '250
Feb '251
Mar '252
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '261
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

British Patient Capital: Health & Life Sciences is the largest displayed sector by deal count (18 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

British Patient Capital: Health & Life Sciences is the largest displayed sector by deal count (18 deals). All available history
SectorDeals
Health & Life Sciences18
Hardware & Robotics10
Data, Analytics & IT8
Fintech8
Enterprise Software7
Space & Frontier Tech6
AI & Machine Learning6
Professional Services6
Networks, Cloud & Communication5
Manufacturing4
Clean Energy & Sustainability3
Consumer & Lifestyle3
AR/VR2
Marketing & Advertising2
Education & Workforce1
E-Commerce & Retail1
Cybersecurity & Privacy1
Transportation & Logistics1
Social & Community Platforms1

Deal Size Distribution

British Patient Capital: 37 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

British Patient Capital: 37 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M4
$25M-$50M13
$50M-$100M11
$100M-$250M9
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

British Patient Capital: Europe has the largest recorded deal count among the displayed regions (35 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

British Patient Capital: Europe has the largest recorded deal count among the displayed regions (35 deals). All available history
RegionDeals
Europe35
United States1
Russian Federation1
British Patient Capital: 20 co-investors are shown, with Oxford Science Enterprises sharing 5 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

British Patient Capital: 20 co-investors are shown, with Oxford Science Enterprises sharing 5 recorded deals. All available history
Co-investorShared deals
Oxford Science Enterprises5
Cambridge Innovation Capital4
IQ Capital4
Northern Gritstone4
Pfizer Ventures4
Epidarex Capital3
In-Q-Tel3
IP Group3
Molten Ventures3
Parkwalk Advisors3
Prosperity7 Ventures3
Sofinnova Partners3
3B Future Health Fund2
ABC Impact2
Advent Life Sciences2
AlbionVC2
ALSA Ventures2
Andera Partners2
BGF2
Canaan Partners2

Investment Strategy

British Patient Capital: Led accounts for 8% and participating for 92% of round participation.All available history.
British Patient Capital: Led accounts for 8% and participating for 92% of round participation. All available history
CategoryDeals (count)Share (%)
Led38%
Participating3492%
British Patient Capital: Single-lead accounts for 67% and co-led for 33% of lead dynamics.All available history.
British Patient Capital: Single-lead accounts for 67% and co-led for 33% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead267%
Co-led133%

Team

Alexandra Woodman

Investment Analyst

Catherine Lewis La Torre CBE

Chief Executive Officer

Chloe Hall

Investment Manager

Emma Johnson

Investment Manager

George Mills

Senior Investment Manager

Ian Connatty

Managing Director, Funds

Max Middleton

Senior Investment Manager

Tom Haywood

Director, Direct Investments